Project Oncology®

177 Episodes

1. Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data

   Published: 3/28/2025
2. AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy

   Published: 3/14/2025
3. Diagnosis and Management of Metastatic PDAC

   Published: 1/13/2025
4. Chemotherapy Strategies for Metastatic PDAC

   Published: 1/13/2025
5. Predictive Models for CAR T-Cell Therapy: Personalizing R/R LBCL Care

   Published: 1/8/2025
6. Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data

   Published: 1/7/2025
7. Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management

   Published: 1/7/2025
8. Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols

   Published: 1/2/2025
9. Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers

   Published: 12/31/2024
10. Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results

    Published: 12/23/2024
11. Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial

    Published: 12/23/2024
12. Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01

    Published: 12/23/2024
13. Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases

    Published: 12/23/2024
14. Understanding Heparin Resistance: Underlying Mechanisms and Alternative Treatment Options

    Published: 12/16/2024
15. The Future of ITP Care: Exploring New Treatments

    Published: 12/16/2024
16. Understanding iMCD Through RNA Sequencing

    Published: 12/16/2024
17. NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker

    Published: 12/13/2024
18. Diagnosing Castleman Disease: Key Considerations

    Published: 12/10/2024
19. Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells

    Published: 12/9/2024
20. Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy

    Published: 11/27/2024